Quince Therapeutics, Inc. (QNCX)
Nasdaq: QNCX · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2016
Who runs Quince Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Thye Dirk
CEO and CMO. First filing May 2022, latest Jan 23, 2026, 3 filings in all.
Officers reporting now
5
of 14 people with a filing in the last fifteen months
Directors reporting now
9
29 people on the record since 2019
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Militello John | Chief Financial Officer | Nov 2026 | Nov 12, 2026 | none |
| Roberts Brigette | Chief Corp. Affairs Officer | Jun 2026 | Jun 11, 2026 | none |
| Thye Dirk | CEO and CMO | May 2022 | Jan 23, 2026 | none |
| Ryan Charles S. | President | Sep 2023 | Jan 23, 2026 | none |
| Hannah Brendan | CBO, COO & CCO | May 2022 | Jan 23, 2026 | none |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bonuccelli Catherine M. | director | Nov 2026 | Nov 12, 2026 | none |
| Patterson Leone D | director | Nov 2026 | Nov 12, 2026 | none |
| Valentine James Elwood | director | Nov 2026 | Nov 12, 2026 | none |
| Wise John Drayton | director | Nov 2026 | Nov 12, 2026 | none |
| Lamond David | director | May 2019 | Jun 15, 2026 | none |
| Senner Christopher J. | director | May 2019 | Jun 15, 2026 | none |
| Bray June | director | Jun 2022 | Jan 21, 2026 | none |
| Mcloughlin Margaret | director | May 2019 | Jan 21, 2026 | none |
| Benatti Luca | director | Oct 2023 | Dec 29, 2025 | 1 · $200,000 |
Earlier names on the record26, newest filing first
Patni Rajiv · director · last filing Jun 2025Ryan Una S · director · last filing Jun 2025Janhofer Guenter · officer · last filing Oct 2023Monohon Ted · officer · last filing Mar 2023Smith Karen L. · officer · last filing Feb 2023Mcdowell Caryn Gordon · officer · last filing Jun 2022Holsinger Leslie · officer · last filing Jun 2022Low Philip S · director · last filing May 2022Sabbagh Marwan · director · last filing Mar 2022Lowe Christopher P. · officer · last filing Mar 2022Detke Michael J. · officer · last filing Mar 2022Lynch Casey · officer · last filing Jan 2022Dominy Stephen S. · officer · last filing Jan 2022Boeding Chad · 10% owner · last filing Feb 2021Epiq Capital Group, LLC · other · last filing Feb 2021Young Kevin · director · last filing Jun 2020Pfizer Inc · 10% owner · last filing Jun 2020Pfizer Strategic Investment Holdings LLC · 10% owner · last filing Jun 2020Pfizer Ventures (Us) LLC · 10% owner · last filing Jun 2020Gafric Kristen · officer · last filing Feb 2020Lamond Christine · 10% owner · last filing May 2019Lamond Pierre · 10% owner · last filing May 2019Takeda Pharmaceutical Co Ltd · 10% owner · last filing May 2019Takeda Pharmaceuticals International AG · 10% owner · last filing May 2019Takeda Pharmaceuticals U.S.A., Inc. · 10% owner · last filing May 2019Takeda Ventures, Inc. · 10% owner · last filing May 2019
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.